A HONG Kong research team has successfully tested a new drug combination that could help tackle the deadly bird flu virus in humans, scientists said in a paper due to be published tomorrow. The use of three drugs together dramatically increased the survival rate of mice who had been infected with the deadly H5N1 virus, the University of Hong Kong team said in a paper to be published a United States-based journal.
And the treatment could help improve the survival chances of people infected with the deadly virus if the success can be replicated in humans, the paper said. “Triple therapy offers some hope for surviving the devastating consequences associated with a pandemic influenza outbreak,” the 13-person team said in a paper to be released in the Proceedings of the National Academy of Sciences. More
Sphere: Related Content